Alzheimers Dement

1. BAIARDI S, Hansson O, Levin J, Parchi P, et al
   In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives.
   Alzheimers Dement. 2024 Jun 21. doi: 10.1002/alz.14039.
   

   >> Share

   
   
2. RAY NR, Kunkle BW, Hamilton-Nelson K, Kurup JT, et al
   Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry.
   Alzheimers Dement. 2024 Jul 3. doi: 10.1002/alz.13880.
   

   >> Share

   
   
3. POLSINELLI AJ, Johnson S, Crouch A, Lane KA, et al
   Neuropsychiatric symptom burden in early-onset and late-onset Alzheimer's disease as a function of age.
   Alzheimers Dement. 2024 Jul 3. doi: 10.1002/alz.14042.
   

   >> Share

   
   
4. MORRIS JC, Buckles VD
   The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer Network.
   Alzheimers Dement. 2024 Jul 3. doi: 10.1002/alz.14106.
   

   >> Share

   
   
5. DAYARATHNA T, Roseborough AD, Gomes J, Khazaee R, et al
   Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer's disease.
   Alzheimers Dement. 2024 Jul 3. doi: 10.1002/alz.14087.
   

   >> Share

   
   
6. GREYSEN SR, Oon AL, Harkins K, Rareshide C, et al
   Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: The STEP 4Life randomized clinical trial.
   Alzheimers Dement. 2024 Jul 4. doi: 10.1002/alz.14058.
   

   >> Share

   
   
7. KIM H, Lee S, Levine A, Huber B, et al
   Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures.
   Alzheimers Dement. 2024 Jul 4. doi: 10.1002/alz.13757.
   

   >> Share

   
   
8. DAMUKA N, Irmen RE, Krizan I, Miller M, et al
   Exploring microtubule dynamics in Alzheimer's disease: Longitudinal assessment using [(11)C]MPC-6827 PET imaging in rodent models of Alzheimer's-related pathology.
   Alzheimers Dement. 2024 Jul 5. doi: 10.1002/alz.14083.
   

   >> Share

   
   
9. ARENAZA-URQUIJO EM, Boyle R, Casaletto K, Anstey KJ, et al
   Sex and gender differences in cognitive resilience to aging and Alzheimer's disease.
   Alzheimers Dement. 2024 Jul 5. doi: 10.1002/alz.13844.
   

   >> Share

   
   

   
   BMC Geriatr

10. ROMERO-MAS M, Cox AM, Ramon-Aribau A, Gomez-Zuniga B, et al
    Knowledge sharing in virtual communities of practice of family caregivers of people with Alzheimer's.
    BMC Geriatr. 2024;24:577.
    

    >> Share

    
    

    
    BMC Neurosci

11. WU S, Zhan P, Wang G, Yu X, et al
    Changes of brain functional network in Alzheimer's disease and frontotemporal dementia: a graph-theoretic analysis.
    BMC Neurosci. 2024;25:30.
    

    >> Share

    
    

    
    Brain

12. NILSSON J, Pichet Binette A, Palmqvist S, Brum WS, et al
    Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
    Brain. 2024;147:2414-2427.
    

    >> Share

    
    
13. OKKELS N, Grothe MJ, Taylor JP, Hasselbalch SG, et al
    Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes.
    Brain. 2024;147:2308-2324.
    

    >> Share

    
    
14. BAUMEISTER H, Vogel JW, Insel PS, Kleineidam L, et al
    A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
    Brain. 2024 Apr 24:awae118. doi: 10.1093.
    

    >> Share

    
    
15. 
    Correction to: Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis.
    Brain. 2024 Jun 28:awae208. doi: 10.1093.
    

    >> Share

    
    
16. HUSAIN M
    The heterogeneity of Alzheimer's disease.
    Brain. 2024;147:2259-2260.
    

    >> Share

    
    

    
    Curr Alzheimer Res

17. PLUTA R
    A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model.
    Curr Alzheimer Res. 2024 Jul 3. doi: 10.2174/0115672050320921240627050736.
    

    >> Share

    
    

    
    J Alzheimers Dis

18. ZUKOWSKI LA, Brinkerhoff SA, Levin I, Herter TM, et al
    Amyloid-beta Deposition Predicts Grocery Shopping Performance in Older Adults Without Cognitive Impairment.
    J Alzheimers Dis. 2024;100:53-75.
    

    >> Share

    
    
19. SANNEMANN L, Bartels C, Brosseron F, Buerger K, et al
    Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
    J Alzheimers Dis. 2024;100:193-205.
    

    >> Share

    
    
20. SHI Q, Liu WS, Liu F, Zeng YX, et al
    The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.
    J Alzheimers Dis. 2024;100:77-85.
    

    >> Share

    
    
21. GIBBONS LE, Mobley T, Mayeda ER, Lee CS, et al
    How Generalizable Are Findings from a Community-Based Prospective Cohort Study? Extending Estimates from the Adult Changes in Thought Study to Its Source Population.
    J Alzheimers Dis. 2024;100:163-174.
    

    >> Share

    
    
22. MENG H, Lv X, Zhang R, Feng Y, et al
    Occurrence and Risk Factors for Cognitive Decline Shared by Couples: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;100:29-40.
    

    >> Share

    
    
23. JIN H, Yang Q, Chen G, Zhang W, et al
    Effects of Hepatorenal Function on Urinary Alzheimer-Associated Neuronal Thread Protein: A Laboratory-Based Cross-Sectional Study Among the Older Chinese Population.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-240148.
    

    >> Share

    
    
24. 
    Erratum to: Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-249011.
    

    >> Share

    
    
25. PUZZO D
    Beyond Amyloid-beta: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 27. doi: 10.3233/JAD-240406.
    

    >> Share

    
    
26. COIMBRA JRM, Resende R, Custodio JBA, Salvador JAR, et al
    BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.
    J Alzheimers Dis. 2024 Jun 22. doi: 10.3233/JAD-240146.
    

    >> Share

    
    
27. GARCIA-MARTINEZ M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, et al
    LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-240067.
    

    >> Share

    
    
28. ZHUANG X, Cordes D, Bender AR, Nandy R, et al
    Classifying Alzheimer's Disease Neuropathology Using Clinical and MRI Measurements.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-231321.
    

    >> Share

    
    
29. LEE CS, Ferguson AN, Gibbons LE, Walker R, et al
    Eye Adult Changes in Thought (Eye ACT) Study: Design and Report on the Inaugural Cohort.
    J Alzheimers Dis. 2024;100:309-320.
    

    >> Share

    
    

    
    J Biol Chem

30. COOPER JM, Lathuiliere A, Su EJ, Song Y, et al
    SORL1 is a receptor for tau that promotes tau seeding.
    J Biol Chem. 2024;300:107313.
    

    >> Share

    
    

    
    J Neurosci

31. STELZER GT, Lima-Filho RAS
    Amyloid-beta as a Key Player in Cerebrovascular Dysfunction in Alzheimer's Disease.
    J Neurosci. 2024;44:e0663242024.
    

    >> Share

    
    

    
    Nat Med

32. JACK CR JR, Andrews SJ, Beach TG, Buracchio T, et al
    Revised criteria for the diagnosis and staging of Alzheimer's disease.
    Nat Med. 2024 Jun 28. doi: 10.1038/s41591-024-02988.
    

    >> Share

    
    
33. ROSENZWEIG N, Kleemann KL, Rust T, Carpenter M, et al
    Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer's disease.
    Nat Med. 2024 Jul 3. doi: 10.1038/s41591-024-03122.
    

    >> Share

    
    

    
    Nat Rev Neurol

34. REKTOROVA I
    Non-invasive stimulation for treating cognitive impairment in Alzheimer disease.
    Nat Rev Neurol. 2024 Jun 29. doi: 10.1038/s41582-024-00976.
    

    >> Share

    
    

    
    Neurobiol Aging

35. DE AVILA C, Suazo C, Nolz J, Nicholas Cochran J, et al
    Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes.
    Neurobiol Aging. 2024;141:160-170.
    

    >> Share

    
    

    
    Neurology

36. VASSILAKI M, Graff-Radford J
    Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2024;103:e209371.
    

    >> Share

    
    
37. CONNOLLY E, O'Connor A, Fallon A, O'Dowd S, et al
    Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2024;103:e209343.
    

    >> Share

    
    
38. GANESH A, Galetta SL
    Editors' Note: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2024;103:e209634.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

39. MALAQUIN S, Lerchundi R, Mougel E, Valette J, et al
    Capturing alterations of intracellular-extracellular lactate distribution in the brain using diffusion-weighted MR spectroscopy in vivo.
    Proc Natl Acad Sci U S A. 2024;121:e2403635121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share